Ligand ID: 486 Drugbank ID: DB00834(Mifepristone) Indication:For the medical termination of intrauterine pregnancy through 49 days' pregnancy. Also indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and are not candidates for surgery or have had unsuccessful surgery. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 5 / 12 | MET B 82GLY B 79VAL B 77CYH B 44CYH B 38 | 1.46A | 21.92 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 5 / 12 | LEU B 282VAL B 204MET B 264LEU B 220MET B 276 | 1.51A | 21.92 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 5 / 12 | LEU B 282GLY B 215LEU B 220PHE B 219MET B 264 | 1.68A | 21.92 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 5 / 12 | LEU A 208LEU A 253PHE A 219LEU A 220CYH A 265 | 1.65A | 21.64 | None | ||
![]() | 4LTW_A_486A302_1 (ANCESTRAL STEROIDRECEPTOR 2) | 1qz8 | POLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU A 94VAL A 102GLN A 11ILE A 91ALA A 54 | 1.24A | 19.28 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 1uj1 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.42A | 22.22 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 1uk2 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 282GLY B 215LEU B 220PHE B 219MET B 264 | 1.56A | 22.22 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 1uw7 | NSP9 (SARS-COVHKU-39849) | 5 / 12 | ASN A 95GLY A 100VAL A 102GLN A -3LEU A -5 | 1.64A | 18.63 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 1x7q | HLA, A-11 (Homosapiens) | 5 / 12 | LEU A 266GLY A 207GLN A 242ARG A 234LEU A 272 | 1.51A | 22.18 | NoneNoneNoneGOL B5004 (-4.3A)None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 1x7q | HLA, A-11 (Homosapiens) | 5 / 12 | LEU A 130LEU A 160GLY A 162VAL A 165ARG A 6 | 1.18A | 20.22 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 1x7q | HLA, A-11 (Homosapiens) | 5 / 12 | LEU A 130LEU A 160GLY A 162VAL A 165ARG A 6 | 1.21A | 20.22 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 1yo4 | HYPOTHETICAL PROTEINX4 (SARSr-CoV) | 4 / 7 | LEU A 62GLU A 77LEU A 82TYR A 60 | 1.70A | 13.03 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 1ysy | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 4 / 7 | LEU A 15ASN A 39LEU A 43MET A 5 | 1.37A | 17.67 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 1z1i | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 72GLY A 71GLN A 19VAL A 18LEU A 67 | 1.54A | 19.14 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN B1072GLY B1071GLN B1019VAL B1018LEU B1067 | 1.64A | 19.88 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 71GLN A 69VAL A 18TRP A 31LEU A 67 | 1.73A | 22.22 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27ASN A 28GLY A 146LEU A 89MET A 17 | 1.50A | 22.22 | None | ||
![]() | 3H52_C_486C4_2 (GLUCOCORTICOIDRECEPTOR) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET B1049CYH B1022PRO B1039 | 1.34A | 22.22 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.46A | 22.22 | None | ||
![]() | 4LTW_A_486A302_1 (ANCESTRAL STEROIDRECEPTOR 2) | 1zv7 | SPIKE GLYCOPROTEIN (SARS-COVFRA) | 5 / 12 | LEU B 26VAL B 22LEU A 26GLU A 15ILE A 16 | 1.29A | 10.32 | None | ||
![]() | 4LTW_A_486A302_1 (ANCESTRAL STEROIDRECEPTOR 2) | 1zv8 | E2 GLYCOPROTEIN (SARSr-CoV) | 6 / 12 | LEU I 20LEU L 30GLN G 17ILE G 16ILE I 16ALA I 12 | 1.74A | 12.18 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 2a5k | 3C-LIKE PEPTIDASE (SARSr-CoV) | 5 / 12 | MET A 6GLY B 138VAL B 171PHE A 3LEU B 141 | 1.70A | 20.78 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2a5k | 3C-LIKE PEPTIDASE (SARSr-CoV) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.67A | 22.16 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 5 / 12 | GLY A 261GLY A 260VAL A 278LEU A 264ILE A 223 | 1.31A | 21.65 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAIN (SARSr-CoV) | 5 / 9 | LEU H 14ALA H 58LEU H 64GLN F 78TYR F 76 | 1.38A | 22.76 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 12 | MET G 134LEU G 122GLN C 68VAL C 71ARG H 80 | 1.76A | 21.25 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 12 | LEU E 96VAL A 27TRP A 34LEU A 61MET A 57 | 1.42A | 21.37 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 12 | LEU B 19GLN C 24VAL C 21MET G 95MET B 57 | 1.60A | 16.87 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 4 / 5 | LEU A 19LEU A 18MET E 92GLN D 23 | 1.39A | 16.67 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 2ajf | ACE2 (Homosapiens) | 5 / 9 | LEU A 236ALA A 443LEU A 450GLN A 522TYR A 587 | 1.39A | 18.60 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2ajf | ACE2 (Homosapiens) | 5 / 12 | LEU A 558GLY A 551GLN A 552PHE A 555MET A 383 | 1.75A | 17.72 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 2ajf | ACE2 (Homosapiens) | 4 / 7 | LEU B 144ASN B 149GLU B 150MET B 152 | 1.58A | 18.56 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2alv | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.70A | 22.22 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 2amd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 6GLY B 138VAL B 171PHE A 3LEU B 141 | 1.65A | 20.66 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 2amd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A -2GLY A -1GLY B 170VAL B 171MET A 6 | 1.58A | 19.94 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 2amd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 208LEU B 253PHE B 219LEU B 220CYH B 265 | 1.65A | 20.73 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 2bx4 | 3C-LIKE PROTEINASE (SARS-COVSin2774) | 5 / 12 | GLY A 71GLN A 19VAL A 18TRP A 31LEU A 67 | 1.42A | 19.14 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU A 87LEU A 67MET A 162TYR A 37 | 1.55A | 20.73 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 282GLY B 215LEU B 220PHE B 219MET B 264 | 1.53A | 22.09 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282VAL A 204MET A 264LEU A 220MET A 276 | 1.51A | 22.09 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27GLY A 146VAL A 148LEU A 87CYH A 22 | 1.58A | 19.94 | ENB A 307 (-3.5A)NoneNoneNoneNone | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B 17LEU B 30VAL B 77LEU B 86LEU B 27 | 1.70A | 19.94 | NoneNoneNoneNoneENB B1145 (-4.2A) | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 2dd8 | IGG HEAVY CHAINIGG LIGHT CHAIN (Homosapiens) | 5 / 12 | LEU H 45GLY L 101GLN L 7PHE L 98LEU L 46 | 1.74A | 20.59 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 12 | GLY B 80GLY B 79VAL B 97LEU B 83ILE B 42 | 1.30A | 22.48 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 12 | LEU A 127LEU A 101GLY A 134MET B 34LEU A 138 | 1.57A | 21.07 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU A 121GLY A 143PHE A 128LEU A 133CYH A 149 | 1.48A | 22.32 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU C 88ASN C 89GLY C 39VAL C 42LEU C 81 | 1.55A | 22.50 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 9 | THR C 91ALA C 146LEU C 118GLN C 98PHE C 96 | 1.60A | 20.30 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 2fyg | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU A 92GLY A 70GLY A 69VAL A 42LEU A 75 | 1.62A | 14.93 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 2g9t | ORF1A POLYPROTEIN (SARSr-CoV) | 5 / 12 | LEU J 92GLY J 70GLY J 69VAL J 42LEU J 75 | 1.53A | 19.91 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 2g9t | ORF1A POLYPROTEIN (SARSr-CoV) | 5 / 12 | LEU J 92GLY J 70GLY J 69VAL J 42LEU J 75 | 1.54A | 19.91 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 2g9t | ORF1A POLYPROTEIN (SARSr-CoV) | 5 / 12 | VAL H 119ARG D 113PHE D 110GLN D 65CYH D 128 | 1.77A | 19.08 | ZN H 999 ( 4.8A)NoneNoneNone ZN D 999 (-1.8A) | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 5 / 12 | MET N 63ASN N 62GLY N 50MET I 63LEU N 45 | 1.70A | 18.71 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 5 / 12 | LEU A 77LEU A 93GLY A 94LEU A 5VAL A 15 | 1.45A | 16.17 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 2gtb | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282VAL A 204MET A 264LEU A 220MET A 276 | 1.55A | 22.16 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 2h85 | PUTATIVE ORF1ABPOLYPROTEIN (SARSr-CoV) | 5 / 12 | LEU A 263LEU A 254GLY A 253VAL A 236LEU A 245 | 1.53A | 20.88 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 2h85 | PUTATIVE ORF1ABPOLYPROTEIN (SARSr-CoV) | 5 / 12 | LEU A 263LEU A 254GLY A 253VAL A 236LEU A 245 | 1.54A | 20.88 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 2hsx | LEADER PROTEIN P65 HOMOLOG NSP1 (SARSr-CoV) | 5 / 12 | LEU A 77LEU A 93GLY A 94LEU A 5CYH A 40 | 1.63A | 16.17 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 2jzf | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 7 | LEU A 603LEU A 533MET A 624MET A 536 | 1.61A | 17.83 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 2k7x | REPLICASEPOLYPROTEIN 1AB MAINPROTEASE (SARS-COVSino1-11) | 4 / 7 | LEU A 205ASN A 203GLU A 288LEU A 282 | 1.55A | 17.31 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2k7x | REPLICASEPOLYPROTEIN 1AB MAINPROTEASE (SARS-COVSino1-11) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.62A | 19.50 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 2k7x | REPLICASEPOLYPROTEIN 1AB MAINPROTEASE (SARS-COVSino1-11) | 5 / 12 | LEU A 282VAL A 204MET A 264LEU A 220MET A 276 | 1.54A | 19.50 | None | ||
![]() | 3H52_C_486C4_2 (GLUCOCORTICOIDRECEPTOR) | 2kqv | NSP3 (SARSr-CoV) | 3 / 3 | MET A 102CYH A 28PRO A 26 | 1.54A | 22.48 | None | ||
![]() | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 2kqw | NSP3 (SARSr-CoV) | 5 / 12 | SER A 142ALA A 144LEU A 164PHE A 181HIS A 173 | 1.79A | 22.58 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 2kys | NSP7 (SARSr-CoV) | 5 / 12 | LEU A 57GLN A 36VAL A 8CYH A 74MET A 77 | 1.37A | 15.02 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 2kys | NSP7 (SARSr-CoV) | 5 / 12 | LEU A 57GLN A 36VAL A 8CYH A 74MET A 77 | 1.36A | 15.02 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 2op9 | REPLICASEPOLYPROTEIN 1AB(PP1AB, ORF1AB)3C-LIKE PROTEINASE(3CL-PRO, 3CLP) (SARSr-CoV) | 5 / 12 | MET A 6GLY B 138VAL B 171PHE A 3LEU B 141 | 1.75A | 20.80 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2op9 | REPLICASEPOLYPROTEIN 1AB(PP1AB, ORF1AB)3C-LIKE PROTEINASE(3CL-PRO, 3CLP) (SARSr-CoV) | 5 / 12 | LEU B 282GLY B 215LEU B 220PHE B 219MET B 264 | 1.63A | 22.16 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 2op9 | REPLICASEPOLYPROTEIN 1AB(PP1AB, ORF1AB)3C-LIKE PROTEINASE(3CL-PRO, 3CLP) (SARSr-CoV) | 5 / 12 | MET B 82GLY B 79VAL B 77CYH B 44CYH B 38 | 1.44A | 22.16 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | LEU B 248GLY B 247GLY B 246VAL B 291LEU B 254 | 1.51A | 21.75 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 4 / 7 | LEU A 299LEU A 331MET A 218TYR A 225 | 1.61A | 22.03 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | LEU B 248GLY B 247GLY B 246VAL B 291LEU B 254 | 1.50A | 21.75 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 2pwx | 3C-LIKE PROTEINASE (SARS-COVBJ01) | 4 / 7 | LEU A 205ASN A 203GLU A 288LEU A 282 | 1.53A | 20.92 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 2pwx | 3C-LIKE PROTEINASE (SARS-COVBJ01) | 5 / 12 | ASN A 28GLY A 29LEU A 89GLN A 69LEU A 75 | 1.72A | 19.88 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 2pwx | 3C-LIKE PROTEINASE (SARS-COVBJ01) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.38A | 22.16 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2pwx | 3C-LIKE PROTEINASE (SARS-COVBJ01) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.75A | 22.16 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 5 / 12 | MET A 6GLY B 138VAL B 171PHE A 3LEU B 141 | 1.75A | 20.48 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 5 / 12 | LEU A 282VAL A 204MET A 264LEU A 220MET A 276 | 1.53A | 21.47 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 5 / 12 | LEU A 27ASN A 28GLY A 29LEU A 89LEU A 67 | 1.71A | 19.88 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 5 / 12 | LEU B 282GLY B 215LEU B 220PHE B 219MET B 264 | 1.59A | 21.47 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 5 / 12 | LEU A 27ASN A 28GLY A 29LEU A 89CYH A 22 | 1.61A | 19.14 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2qc2 | 3C-LIKE PROTEINASE (-) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.67A | 22.16 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 2qc2 | 3C-LIKE PROTEINASE (-) | 5 / 12 | LEU B 282VAL B 204MET B 264LEU B 220MET B 276 | 1.51A | 22.16 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 2qcy | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 28GLY A 29LEU A 89GLN A 69LEU A 75 | 1.71A | 19.88 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 2qcy | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.45A | 22.22 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2qcy | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.71A | 22.22 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 2qiq | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU A 208LEU A 253PHE A 219LEU A 220CYH A 265 | 1.63A | 18.92 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2qiq | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.65A | 21.26 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | LEU E 263LEU E 254GLY E 253VAL E 236LEU E 245 | 1.53A | 20.39 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | LEU E 263LEU E 254GLY E 253VAL E 236LEU E 245 | 1.53A | 20.39 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 4 / 7 | LEU F 2ASN C 52GLU C 56MET C 104 | 1.65A | 21.15 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 2rnk | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 5 | LEU A 603LEU A 546MET A 536TYR A 644 | 1.67A | 16.86 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.42A | 22.03 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 27ASN B 28GLY B 146LEU B 89MET B 17 | 1.55A | 22.03 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 282GLY B 215LEU B 220PHE B 219MET B 264 | 1.66A | 22.03 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 2w2g | NSP3 (SARSr-CoV) | 5 / 9 | THR B 649LEU B 648LEU B 617THR B 528LEU B 526 | 1.63A | 21.62 | None | ||
![]() | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 2xyr | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | SER A 129ALA A 168TYR A 47LEU A 85PHE A 103 | 1.63A | 21.97 | NoneNoneSFG A1298 (-4.6A)NoneNone | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 2z3d | REPLICASEPOLYPROTEIN 1AB(PP1AB) (SARSr-CoV) | 5 / 9 | THR A 169LEU A 167ALA A 194PHE A 185LEU I 902 | 1.67A | 20.68 | NoneNoneNoneNoneACE I 901 ( 3.8A) | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 2z9j | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU A 205ASN A 203GLU A 288LEU A 282 | 1.50A | 20.77 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 2z9k | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27ASN A 28GLY A 29LEU A 89LEU A 67 | 1.61A | 19.88 | DOZ A 901 (-3.6A)NoneNoneNoneNone | ||
![]() | 3H52_C_486C4_2 (GLUCOCORTICOIDRECEPTOR) | 3atw | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET A 6CYH B 117PRO A 9 | 1.79A | 22.22 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 3avz | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27ASN A 28GLY A 146LEU A 89MET A 17 | 1.50A | 22.22 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 3avz | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27ASN A 28GLY A 29VAL A 36LEU A 67 | 1.55A | 19.88 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3avz | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.65A | 22.22 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 3aw0 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 71GLN A 69VAL A 18TRP A 31LEU A 67 | 1.62A | 19.14 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 3aw0 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 208LEU A 253PHE A 219LEU A 220CYH A 265 | 1.59A | 20.77 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 3aw1 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B 82GLY B 79VAL B 77CYH B 44CYH B 38 | 1.38A | 22.22 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 3bgf | F26G19 FAB (Musmusculus) | 5 / 9 | THR L 53ALA L 50LEU H 100GLN L 90TYR L 71 | 1.62A | 20.99 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 3d0g | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | MET A 557LEU A 558ASN A 556GLY A 551MET A 408 | 1.68A | 19.80 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 3d0g | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 9 | LEU A 236ALA A 443LEU A 450GLN A 522TYR A 587 | 1.35A | 18.77 | None | ||
![]() | 3H52_B_486B1_1 (GLUCOCORTICOIDRECEPTOR) | 3d0g | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 10 | LEU A 392ASN A 394TRP A 69GLN A 98LEU A 100 | 1.74A | 18.40 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3d0g | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU A 558GLY A 551GLN A 552PHE A 555MET A 383 | 1.56A | 18.40 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 7 | ASN A 188LEU A 108MET A 123MET A 190 | 1.38A | 18.38 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | GLY A 377GLN A 380PHE A 314GLN A 526LEU A 529 | 1.46A | 17.89 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 3d0i | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 5 | LEU B 584LEU B 585MET B 579GLN B 522 | 1.77A | 17.89 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 208LEU A 253PHE A 219LEU A 220CYH A 265 | 1.64A | 18.42 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.50A | 22.46 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 5 | LEU A 268LEU A 208MET A 276GLN A 273 | 1.55A | 19.88 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.71A | 22.46 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 3e9s | NSP3 (SARSr-CoV) | 5 / 12 | LEU A 88ASN A 89GLY A 39VAL A 42LEU A 81 | 1.72A | 23.33 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 3e9s | NSP3 (SARSr-CoV) | 5 / 9 | THR A 103LEU A 118ALA A 140LEU A 151PHE A 148 | 1.61A | 20.73 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 3e9s | NSP3 (SARSr-CoV) | 5 / 12 | LEU A 121GLY A 143PHE A 128LEU A 133CYH A 149 | 1.56A | 22.54 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3ea7 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 282GLY B 215LEU B 220PHE B 219MET B 264 | 1.66A | 21.88 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 3ea7 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN B 28GLY B 29LEU B 89GLN B 69LEU B 75 | 1.71A | 19.50 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 3ea7 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 27ASN B 28GLY B 146LEU B 89MET B 17 | 1.53A | 21.88 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 3ea7 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B 6GLY A 138VAL A 171PHE B 3LEU A 141 | 1.65A | 20.18 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 3ea8 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 208LEU A 253PHE A 219LEU A 220CYH A 265 | 1.64A | 20.77 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 3ea8 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.47A | 21.88 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 3ea9 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27GLY A 146VAL A 148LEU A 87CYH A 22 | 1.59A | 18.81 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 3ea9 | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU A 87LEU A 67MET A 162TYR A 37 | 1.59A | 19.80 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3ea9 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.66A | 21.88 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 3ea9 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27GLY A 146VAL A 148LEU A 87CYH A 22 | 1.59A | 18.81 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.45A | 21.88 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27ASN A 28GLY A 146LEU A 89MET A 17 | 1.51A | 21.88 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3ebn | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU B 282GLY D 215LEU D 220PHE D 219MET B 264 | 1.62A | 19.50 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 3ebn | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU D 282VAL B 204MET D 264LEU B 220MET D 276 | 1.53A | 19.50 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 3ee7 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | LEU A 103LEU B 97GLY A 100GLY B 100CYH A 73 | 1.58A | 19.91 | None | ||
![]() | 4LTW_A_486A302_1 (ANCESTRAL STEROIDRECEPTOR 2) | 3ee7 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | LEU C 94VAL C 102GLN C 11ILE C 91ALA C 54 | 1.13A | 19.05 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 3ee7 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | ASN C 96GLY C 100GLY D 100LEU C 106CYH C 73 | 1.39A | 19.91 | PO4 D 124 ( 3.2A)NoneNoneNoneNone | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 3ee7 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | LEU A 97ASN A 96GLY A 100VAL A 102LEU A 4 | 1.42A | 15.71 | NoneGOL A 128 ( 3.7A)NoneNoneNone | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 3ee7 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 7 | LEU D 4ASN D 33LEU D 97MET D 101 | 1.52A | 17.31 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 3f9e | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.43A | 21.86 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 3f9f | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 282VAL B 204MET B 264LEU B 220MET B 276 | 1.52A | 22.16 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 3f9f | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 71GLN B 19VAL B 18TRP B 31LEU B 67 | 1.54A | 19.41 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 3f9f | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.44A | 22.16 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B 82GLY B 79VAL B 77CYH B 44CYH B 38 | 1.45A | 22.16 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27ASN A 28GLY A 29LEU A 89LEU A 67 | 1.68A | 19.88 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.66A | 22.16 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 71GLN A 19VAL A 18TRP A 31LEU A 67 | 1.46A | 19.40 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 282VAL B 204MET B 264LEU B 220MET B 276 | 1.53A | 22.16 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3f9h | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 282GLY B 215LEU B 220PHE B 219MET B 264 | 1.59A | 22.16 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 3f9h | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27ASN A 28GLY A 29LEU A 89LEU A 67 | 1.62A | 19.88 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.44A | 20.50 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.69A | 20.50 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 3i6g | HLA, A-2 (Homosapiens) | 5 / 12 | LEU D 130LEU D 160GLY D 162VAL D 165ARG D 6 | 1.12A | 19.93 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 3i6g | HLA, A-2MEMBRANE PROTEIN (Homosapiens) | 4 / 5 | LEU D 126LEU D 130MET F 2TYR D 116 | 1.64A | 20.88 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 3i6g | HLA, A-2 (Homosapiens) | 5 / 12 | LEU D 130LEU D 160GLY D 162VAL D 165ARG D 6 | 1.11A | 19.93 | None | ||
![]() | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 3i6l | HLA, A-24 (Homosapiens) | 5 / 12 | ASN D 174GLY D 175PHE D 33MET D 5LEU D 168 | 1.46A | 19.72 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 3i6l | HLA, A-24 (Homosapiens) | 5 / 12 | LEU D 130LEU D 160GLY D 162VAL D 165ARG D 6 | 1.19A | 20.80 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 3i6l | HLA, A-24 (Homosapiens) | 5 / 12 | LEU D 130LEU D 160GLY D 162VAL D 165ARG D 6 | 1.21A | 20.80 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 27ASN B 28GLY B 146LEU B 89MET B 17 | 1.48A | 22.22 | PJE F 5 ( 4.4A)NoneNoneNoneNone | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 27ASN B 28GLY B 146LEU B 89MET B 17 | 1.55A | 22.22 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B 82GLY B 79VAL B 77CYH B 44CYH B 38 | 1.42A | 22.22 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 208LEU B 253PHE B 219LEU B 220CYH B 265 | 1.64A | 20.77 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 6GLY B 138VAL B 171PHE A 3LEU B 141 | 1.66A | 20.48 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 3m3t | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.46A | 22.16 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 3m3t | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 28GLY A 29LEU A 89GLN A 69LEU A 75 | 1.73A | 19.88 | None | ||
![]() | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 3m3t | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASN A 214GLY A -1ARG A 279PHE A 219MET A 264 | 1.75A | 21.08 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3m3t | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.57A | 22.16 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 282VAL B 204MET B 264LEU B 220MET B 276 | 1.53A | 21.82 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27ASN A 28GLY A 29LEU A 89LEU A 67 | 1.72A | 19.50 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 282GLY B 215LEU B 220PHE B 219MET B 264 | 1.58A | 21.82 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 3mj5 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | LEU B 121GLY B 143PHE B 128LEU B 133CYH B 149 | 1.50A | 22.09 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 3mj5 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 5 | LEU B 118LEU B 114MET B 170GLN B 123 | 1.71A | 23.36 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 3r24 | 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 7 | LEU A 59GLU A 276LEU A 275MET A 65 | 1.68A | 22.07 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 3r24 | 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | LEU A 126GLY A 165GLY A 164LEU A 252CYH A 51 | 1.52A | 22.64 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 3sci | ACE2 (Homosapiens) | 5 / 12 | GLY A 377GLN A 380PHE A 314GLN A 526LEU A 529 | 1.53A | 16.31 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 3sci | ACE2 (Homosapiens) | 4 / 5 | LEU A 584LEU A 585MET A 579GLN A 522 | 1.77A | 16.31 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 3scj | ACE2 (Homosapiens) | 5 / 9 | LEU A 236ALA A 443LEU A 450GLN A 522TYR A 587 | 1.34A | 17.79 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 3scj | ACE2 (Homosapiens) | 5 / 12 | MET A 557LEU A 558ASN A 556GLY A 551MET A 408 | 1.69A | 19.11 | None | ||
![]() | 3H52_D_486D2_2 (GLUCOCORTICOIDRECEPTOR) | 3scj | ACE2 (Homosapiens) | 4 / 5 | LEU B 176TRP B 459MET B 474TYR B 183 | 1.76A | 16.94 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 9 | LEU A 236ALA A 443LEU A 450GLN A 522TYR A 587 | 1.36A | 17.96 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | GLY B 377GLN B 380PHE B 314GLN B 526LEU B 529 | 1.50A | 17.11 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 7 | LEU A 558ASN A 556GLU A 571LEU A 568 | 1.57A | 17.88 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | MET A 557LEU A 558ASN A 556GLY A 551MET A 408 | 1.67A | 18.95 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3scl | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU B 558GLY B 551GLN B 552PHE B 555MET B 383 | 1.73A | 17.60 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 3sna | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.70A | 22.22 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 3snc | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 208LEU A 253PHE A 219LEU A 220CYH A 265 | 1.55A | 20.77 | None | ||
![]() | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 3to2 | MHC CLASS I ANTIGEN (Homosapiens) | 5 / 12 | ASN A 174GLY A 175PHE A 33MET A 5LEU A 168 | 1.43A | 20.88 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 3vb6 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B 6GLY A 138VAL A 171PHE B 3LEU A 141 | 1.64A | 20.48 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282GLY A 215LEU A 220PHE A 219MET A 264 | 1.67A | 21.26 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 208LEU A 253PHE A 219LEU A 220CYH A 265 | 1.66A | 21.78 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.49A | 21.26 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27ASN A 28GLY A 29VAL A 36LEU A 67 | 1.69A | 20.12 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 282VAL B 204MET B 264LEU B 220MET B 276 | 1.53A | 21.26 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 9 | THR A 91ALA A 146LEU A 118GLN A 98PHE A 96 | 1.67A | 20.59 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | GLY A 101GLY A 100GLN A 98VAL A 99CYH A 261 | 1.29A | 21.79 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | LEU A 121GLY A 143PHE A 128LEU A 133CYH A 149 | 1.56A | 22.51 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 4mds | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 27ASN A 28GLY A 146LEU A 89MET A 17 | 1.53A | 22.22 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 4mds | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 82GLY A 79VAL A 77CYH A 44CYH A 38 | 1.47A | 22.22 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 4mm3 | PAPAIN-LIKEPROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 101GLY B 100GLN B 98VAL B 99CYH B 261 | 1.28A | 21.71 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 4ovz | PAPAIN-LIKEPROTEINASE (SARS-COVUrbani) | 5 / 9 | THR B 91ALA B 146LEU B 118GLN B 98PHE B 96 | 1.59A | 20.48 | None | ||
![]() | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 4ovz | PAPAIN-LIKEPROTEINASE (SARS-COVUrbani) | 5 / 12 | SER B 240ALA B 205TYR B 214LEU B 235LYS B 218 | 1.68A | 22.53 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 4ow0 | PAPAIN-LIKE PROTEASE (SARS-COVUrbani) | 5 / 12 | LEU A 88ASN A 89GLY A 39VAL A 42LEU A 81 | 1.66A | 22.49 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 4ow0 | PAPAIN-LIKE PROTEASE (SARS-COVUrbani) | 4 / 7 | ASN B 178GLU A 78LEU A 76TYR B 137 | 1.24A | 22.09 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 4rna | PAPAIN-LIKE PROTEASE (Humanbetacoronavirus2cEMC/2012) | 5 / 12 | LEU A 246GLY A 211GLN A 315MET A 185LEU A 236 | 1.62A | 24.19 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 4rna | PAPAIN-LIKE PROTEASE (Humanbetacoronavirus2cEMC/2012) | 5 / 12 | LEU A 246GLY A 211GLN A 315MET A 185LEU A 236 | 1.54A | 23.41 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 4tww | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET A 6GLY B 138VAL B 171PHE A 3LEU B 141 | 1.79A | 20.48 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 5b6o | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | MET B 82GLY B 79VAL B 77CYH B 44CYH B 38 | 1.45A | 20.53 | None | ||
![]() | 3H52_C_486C4_2 (GLUCOCORTICOIDRECEPTOR) | 5b6o | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | MET B 165CYH B 85PRO B 39 | 1.61A | 20.53 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 5b6o | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 208LEU A 253PHE A 219LEU A 220CYH A 265 | 1.62A | 22.22 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 5b6o | 3C-LIKE PROTEINASE (SARSr-CoV) | 4 / 7 | LEU A 227ASN A 231LEU A 272MET A 235 | 1.69A | 22.22 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 5c8s | NSP10 (SARSr-CoV) | 5 / 12 | LEU A 92GLY A 70VAL A 42LEU A 75CYH A 77 | 1.67A | 20.75 | NoneNoneNoneNone ZN A 201 (-2.2A) | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 4 / 7 | LEU D 105ASN D 104GLU D 92LEU D 149 | 1.39A | 18.56 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | GLY B 110GLN B 108VAL B 91LEU B 152LEU B 157 | 1.63A | 19.89 | None | ||
![]() | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | GLY B 110GLN B 108VAL B 91LEU B 152LEU B 157 | 1.74A | 19.20 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | LEU B 117ASN B 116LEU B 109GLY B 110LEU B 170 | 1.61A | 18.71 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 5c8t | NSP10 (SARSr-CoV) | 5 / 12 | LEU C 92GLY C 70GLY C 69VAL C 42LEU C 75 | 1.60A | 17.57 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 5c8t | NSP10 (SARSr-CoV) | 5 / 12 | LEU C 92GLY C 70GLY C 69VAL C 42LEU C 75 | 1.61A | 17.57 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 5c8u | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 4 / 7 | LEU D 105ASN D 104GLU D 92LEU D 149 | 1.43A | 18.56 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | GLY D 101GLY D 100GLN D 98VAL D 99ILE D 286 | 1.30A | 21.86 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 5e6j | REPLICASEPOLYPROTEIN 1ABUBIQUITIN (SARSr-CoV;syntheticconstruct) | 4 / 5 | LEU E 71LEU E 69MET D 209TYR D 265 | 1.70A | None | |||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU A 121GLY A 143PHE A 128LEU A 133CYH A 149 | 1.54A | 22.00 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 5f22 | NSP8NSP7 (SARSr-CoV) | 5 / 12 | LEU B 96VAL A 27TRP A 34LEU A 61MET A 57 | 1.63A | 19.30 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | LEU O 92GLY O 70GLY O 69VAL O 42LEU O 75 | 1.61A | 15.91 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | LEU O 92GLY O 70GLY O 69VAL O 42LEU O 75 | 1.60A | 15.91 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 4 / 7 | LEU B 105ASN B 104GLU B 92LEU B 149 | 1.66A | 18.76 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU B 17GLY D 101GLY D 100GLN D 98VAL D 99 | 1.37A | 23.71 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU B 17GLY D 101GLN D 98VAL D 99PHE B 9 | 1.61A | 23.36 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU B 88ASN B 89GLY B 39VAL B 42LEU B 81 | 1.57A | 22.73 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU D 121GLY D 143PHE D 128LEU D 133CYH D 149 | 1.55A | 22.48 | None | ||
![]() | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 5x4r | S PROTEIN (MERS-CoV) | 5 / 12 | ARG A 307SER A 302ALA A 92ILE A 131HIS A 208 | 1.67A | 21.08 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | LEU A 374ASN A 375GLY A 512VAL A 349CYH A 419 | 1.57A | 10.50 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 9 | THR A 631ALA A 633LEU B 843GLN A 301LEU A 636 | 1.50A | 10.82 | None | ||
![]() | 3H52_C_486C4_2 (GLUCOCORTICOIDRECEPTOR) | 5x59 | S PROTEIN (MERS-CoV) | 3 / 3 | MET B 943CYH A 727PRO A 730 | 1.25A | 11.17 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 5x59 | S PROTEIN (MERS-CoV) | 5 / 12 | LEU A 402GLN A 471PHE A 385LEU A 414VAL A 396 | 1.47A | 11.19 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 5x59 | S PROTEIN (MERS-CoV) | 4 / 7 | LEU C 840ASN C 839LEU C1086TYR B 361 | 1.61A | 11.19 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | LEU A 736ASN C 951GLY A 739GLN C 56LEU C 54 | 1.62A | 13.06 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | GLY B 781GLN B 902PHE B 880GLN B 786MET B1032 | 1.68A | 11.68 | None | ||
![]() | 3QT0_A_486A4_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 4 | LYS B1010GLN B 766ILE B 852LEU B 930 | 1.78A | 12.91 | None | ||
![]() | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | ASN B 910GLY B 781PHE B 880MET B1032LEU B 898 | 1.75A | 11.68 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 5 | LEU A 944LEU A 840MET A 713GLN A 992 | 1.43A | None | |||
![]() | 4LTW_A_486A302_1 (ANCESTRAL STEROIDRECEPTOR 2) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | LEU A1045ILE A 913GLN A 917GLU A 801ILE A 800 | 1.26A | 10.82 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 5x5c | S PROTEIN (MERS-CoV) | 5 / 12 | LEU C 893PHE C1012GLN C1009MET C1137LEU C 873 | 1.66A | 10.50 | None | ||
![]() | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 5x5c | S PROTEIN (MERS-CoV) | 5 / 12 | ARG B 307SER B 302ALA B 92ILE B 131HIS B 208 | 1.67A | 11.48 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU A 734ASN A 733LEU A 735LEU A 959ARG A 982 | 1.55A | 10.56 | LEU A 734 ( 0.6A)ASN A 733 ( 0.6A)LEU A 735 ( 0.6A)LEU A 959 ( 0.6A)ARG A 982 ( 0.6A) | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU A 538GLY A 311PHE A 529LEU A 532VAL A 308 | 1.52A | 12.05 | LEU A 538 ( 0.6A)GLY A 311 ( 0.0A)PHE A 529 ( 1.3A)LEU A 532 ( 0.5A)VAL A 308 ( 0.6A) | ||
![]() | 4LTW_A_486A302_1 (ANCESTRAL STEROIDRECEPTOR 2) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU B1045ILE B 913GLN B 917GLU B 801ILE B 800 | 1.30A | 11.57 | LEU B1045 ( 0.6A)ILE B 913 ( 0.4A)GLN B 917 ( 0.6A)GLU B 801 ( 0.5A)ILE B 800 ( 0.7A) | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | THR C 923LEU C 920ALA C 926LEU C 930THR C 706 | 1.41A | 11.57 | THR C 923 ( 0.8A)LEU C 920 ( 0.6A)ALA C 926 ( 0.0A)LEU C 930 ( 0.6A)THR C 706 ( 0.8A) | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU B 504ASN B 505VAL B 382LEU B 377GLN B 550 | 1.72A | 12.93 | LEU B 504 ( 0.6A)ASN B 505 ( 0.6A)VAL B 382 ( 0.6A)LEU B 377 ( 0.6A)GLN B 550 ( 0.6A) | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 5y3q | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 9 | THR A 91ALA A 146LEU A 118GLN A 98PHE A 96 | 1.69A | 20.54 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 5y3q | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | LEU A 121GLY A 143PHE A 128LEU A 133CYH A 149 | 1.58A | 21.28 | None | ||
![]() | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) | 5zvm | PAN-COV INHIBITORYPEPTIDE EK1SPIKE GLYCOPROTEIN (SARSr-CoV;syntheticconstruct) | 5 / 12 | GLN A 931VAL A 933LEU A 927MET b 22LEU C 927 | 1.44A | 18.50 | None | ||
![]() | 3QT0_A_486A4_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 5zvm | PAN-COV INHIBITORYPEPTIDE EK1SPIKE GLYCOPROTEIN (SARSr-CoV;syntheticconstruct) | 4 / 4 | LYS b 40GLN C 908ILE A 905LEU A 898 | 1.09A | 17.65 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 6acg | ACE2 (Homosapiens) | 4 / 7 | LEU D 148ASN D 149LEU D 267TYR D 127 | 1.66A | 17.74 | None | ||
![]() | 3H52_B_486B1_2 (GLUCOCORTICOIDRECEPTOR) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLY B 780GLY B 781GLN B 902LEU B 898ILE B 913 | 1.34A | 12.09 | None | ||
![]() | 3H52_C_486C4_1 (GLUCOCORTICOIDRECEPTOR) | 6acj | ACE2 (Homosapiens) | 5 / 12 | LEU D 558GLY D 551GLN D 552PHE D 555MET D 383 | 1.64A | 16.94 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU C 374GLY C 512VAL C 349PHE C 501LEU C 355 | 1.60A | 11.37 | None | ||
![]() | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | SER A 957ALA A 954LEU A 959ILE A 724PHE B 558 | 1.56A | 12.44 | None | ||
![]() | 3H52_A_486A3_1 (GLUCOCORTICOIDRECEPTOR) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN B 118GLY B 100VAL B 102LEU B 194ILE B 125 | 1.56A | 12.09 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU B 538GLY B 311PHE B 529LEU B 532VAL B 308 | 1.50A | 12.05 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 6acj | ACE2 (Homosapiens) | 5 / 12 | LEU D 450GLY D 448ARG D 518LEU D 503VAL D 244 | 1.63A | 17.74 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN A 375LEU A 377GLY A 512VAL A 510LEU A 503 | 1.47A | 10.56 | None | ||
![]() | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN C 907GLY C 781PHE C 909MET C 884LEU C 898 | 1.69A | 11.37 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 6 / 9 | THR A 236LEU A 235ALA A 237GLN A 26PHE A 76THR A 71 | 1.51A | 11.57 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU A 944ASN A 942VAL A 842LEU A 749GLN A 992 | 1.25A | 13.35 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 5 | LEU B 944LEU B 840MET B 713GLN B 992 | 1.37A | None | |||
![]() | 4LTW_A_486A302_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU A1045GLN A 915ILE A 916GLN A 917ILE A 800 | 1.24A | 11.57 | None | ||
![]() | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY B 634GLN B 630VAL B 601LEU C 831LEU C 823 | 1.72A | 11.97 | NoneNAG B1311 (-3.1A)NoneNAG B1311 (-4.9A)None | ||
![]() | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | SER C 957ALA C 954LEU C 959ILE C 724PHE B 558 | 1.70A | 12.70 | None | ||
![]() | 4LTW_A_486A302_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | LEU A1045GLN A 915ILE A 916GLN A 917ILE A 800 | 1.33A | 12.14 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 9 | LEU B 538LEU B 532GLN B 550PHE B 529LEU B 519 | 1.55A | 12.14 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | LEU B 944ASN B 942VAL B 842LEU B 749GLN B 992 | 1.45A | 13.08 | None | ||
![]() | 4LTW_A_486A302_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | LEU C1045ILE C 913GLN C 917GLU C 801ILE C 800 | 1.15A | 12.18 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | LEU C 374LEU C 377GLY C 512VAL C 349LEU C 355 | 1.24A | 11.16 | None | ||
![]() | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY B 634GLN B 630VAL B 601LEU C 831LEU C 823 | 1.66A | 12.00 | NoneNAG B1301 ( 4.6A)NoneNoneNone | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | LEU C 374LEU C 377GLY C 512VAL C 349LEU C 355 | 1.22A | 11.16 | None | ||
![]() | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 6crz | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | SER C 957ALA C 954LEU C 959ILE C 724PHE B 558 | 1.60A | 12.65 | None | ||
![]() | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 6crz | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ASN A 910GLY A 781PHE A 880MET A 884LEU A 898 | 1.60A | 11.65 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6cs0 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 9 | LEU B 538LEU B 532GLN B 550PHE B 529LEU B 519 | 1.51A | 12.18 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 6cs1 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 7 | ASN B 281GLU B 285MET B 37TYR B 63 | 1.64A | 11.99 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 6cs2 | ACE2 (Homosapiens) | 5 / 12 | GLY D 377GLN D 380PHE D 314GLN D 526LEU D 529 | 1.75A | 16.26 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY B 953GLN C 737PHE B 952GLN C 984LEU C 983 | 1.64A | 11.65 | None | ||
![]() | 3H52_D_486D2_2 (GLUCOCORTICOIDRECEPTOR) | 6cs2 | ACE2 (Homosapiens) | 4 / 5 | LEU D 176TRP D 459MET D 474TYR D 183 | 1.78A | 17.72 | None | ||
![]() | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 6iex | MHC CLASS I ANTIGEN (Homosapiens) | 5 / 12 | ASN A 174GLY A 175PHE A 33MET A 5LEU A 168 | 1.54A | 21.02 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 6iex | MHC CLASS I ANTIGEN (Homosapiens) | 5 / 12 | LEU A 266GLY A 207GLN A 242ARG A 234LEU A 272 | 1.42A | 22.07 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 6iex | MHC CLASS I ANTIGEN (Homosapiens) | 5 / 12 | LEU A 130LEU A 160GLY A 162VAL A 165ARG A 6 | 1.29A | 21.77 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 6iex | MHC CLASS I ANTIGEN (Homosapiens;SARSr-CoV) | 4 / 7 | LEU C 8ASN A 70LEU A 78TYR A 99 | 1.38A | 5.84 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 6iex | MHC CLASS I ANTIGEN (Homosapiens) | 5 / 12 | LEU A 130LEU A 160GLY A 162VAL A 165ARG A 6 | 1.28A | 21.77 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 6jyt | HELICASE (SARSr-CoV) | 4 / 7 | LEU A 384ASN A 388LEU A 363TYR A 277 | 1.33A | 17.77 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | LEU A 219ASN A 220GLY A 222LEU A 165LEU A 158 | 1.62A | 18.32 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6jyt | HELICASE (SARSr-CoV) | 5 / 9 | THR B 153LEU B 165LEU B 227TYR B 198LEU B 219 | 1.48A | 16.67 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6m17 | ACE2 (Homosapiens) | 5 / 9 | LEU D 444LEU D 262TYR D 243THR D 282LEU D 440 | 1.53A | 16.30 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 6m17 | ACE2 (Homosapiens) | 5 / 12 | GLY D 377GLN D 380PHE D 314GLN D 526LEU D 529 | 1.43A | 16.95 | None | ||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | LEU C 11ASN C 8GLY C 510VAL C 506LEU C 96 | 1.54A | 16.04 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 9 | THR C 474LEU C 201LEU C 468PHE C 467LEU C 199 | 1.60A | 17.67 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 6m18 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 4 / 7 | LEU C 61LEU C 75TYR C 322MET C 71 | 1.45A | 16.15 | None | ||
![]() | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 6m18 | ACE2 (Homosapiens) | 5 / 12 | ARG D 697SER D 617LEU D 725ILE D 704PHE D 681 | 1.65A | 16.42 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | LEU C 429GLY C 428PHE C 141LEU C 140VAL C 55 | 1.45A | 16.15 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 6m1d | ACE2 (Homosapiens) | 4 / 7 | LEU B 554ASN B 556GLU B 571LEU B 568 | 1.47A | 16.43 | None | ||
![]() | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | SER C 323ALA C 247LEU C 244ILE C 236PHE C 403 | 1.79A | 16.51 | None | ||
![]() | 4LTW_A_486A302_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU C1045GLN C 915ILE C 916GLN C 917ILE C 800 | 1.18A | 11.84 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | THR A 923LEU A 920ALA A 926LEU A 930THR A 706 | 1.47A | 11.84 | None | ||
![]() | 5UC3_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASN B 910GLY B 781PHE B 880MET B1032LEU B 898 | 1.65A | 11.67 | None | ||
![]() | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,HEAVY CHAIN (Homosapiens) | 5 / 12 | GLY H 120VAL H 5LEU H 81MET H 83LEU H 18 | 1.68A | 20.59 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,LIGHT CHAIN (Homosapiens) | 4 / 5 | LEU L 52MET L 94GLN L 55TYR L 37 | 1.62A | None | |||
![]() | 5UC1_B_486B801_2 (GLUCOCORTICOIDRECEPTOR) | 6nur | NSP7NSP8 (SARSr-CoV) | 5 / 12 | LEU C 17LEU C 20GLN D 88VAL C 66LEU D 91 | 1.52A | 15.02 | None | ||
![]() | 2W8Y_A_486A1000_1 (PROGESTERONERECEPTOR) | 6nur | NSP12 (SARSr-CoV) | 5 / 12 | LEU A 351LEU A 329GLY A 327PHE A 652VAL A 675 | 1.61A | 13.21 | None | ||
![]() | 5UC1_A_486A801_1 (GLUCOCORTICOIDRECEPTOR) | 6nur | NSP7NSP8 (SARSr-CoV) | 5 / 12 | LEU C 17LEU C 20GLN D 88VAL C 66LEU D 91 | 1.52A | 15.02 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 6nur | NSP7 (SARSr-CoV) | 4 / 5 | LEU C 14LEU C 55MET C 62GLN C 18 | 1.57A | None | |||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 6nus | NSP8 (SARSr-CoV) | 4 / 7 | LEU B 169ASN B 145GLU B 155LEU B 189 | 1.61A | 20.00 | None | ||
![]() | 2W8Y_A_486A1000_2 (PROGESTERONERECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 4 / 7 | LEU A 630GLU A 658LEU A 638TYR A 619 | 1.26A | 13.21 | None | ||
![]() | 4LTW_A_486A303_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6nus | NSP8 (SARSr-CoV) | 5 / 9 | THR B 124ALA B 125LEU B 189TYR B 149LEU B 122 | 1.53A | 23.51 | None | ||
![]() | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 5 / 12 | MET A 242GLN A 698VAL A 700LEU A 630LEU A 308 | 1.79A | 14.00 | None | ||
![]() | 3H52_C_486C4_2 (GLUCOCORTICOIDRECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 3 / 3 | MET A 756CYH A 813PRO A 809 | 1.48A | 14.00 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 5 / 12 | LEU A 212ASN A 213GLY A 214GLN A 210LEU A 241 | 1.44A | 14.67 | None | ||
![]() | 5UC3_A_486A801_2 (GLUCOCORTICOIDRECEPTOR) | 6nus | NSP12 (SARSr-CoV) | 4 / 5 | LEU A 241LEU A 240MET A 463TYR A 286 | 1.57A | None | |||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 6vw1 | ACE2 (Homosapiens) | 5 / 12 | GLY B 377GLN B 380PHE B 314GLN B 526LEU B 529 | 1.44A | 17.06 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 6vw1 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | LEU F 387GLY F 526VAL F 362PHE F 515LEU F 368 | 1.65A | 22.87 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | MET H 100GLY H 104GLN H 6GLN L 89LEU H 45 | 1.60A | 22.01 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | MET H 100GLY H 104GLN H 6GLN L 89LEU H 45 | 1.65A | 19.84 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | MET B 106GLY B 110GLN B 6GLN C 95LEU B 45 | 1.66A | 20.86 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | MET H 106GLY H 110GLN H 6GLN L 95LEU H 45 | 1.60A | 20.86 | None | ||
![]() | 4LTW_A_486A302_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 12 | LEU B 4VAL B 5GLN H 6GLN H 3MET B 2 | 1.77A | None | |||
![]() | 4LTW_A_486A302_1 (ANCESTRAL STEROIDRECEPTOR 2) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 12 | LEU H 4VAL H 5GLN B 6GLN B 3MET H 2 | 1.77A | None | |||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | MET B 106GLY B 110GLN B 6GLN C 95LEU B 45 | 1.70A | 19.00 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | MET H 106GLY H 110GLN H 6GLN L 95LEU H 45 | 1.65A | 19.00 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | MET H 106GLY H 110GLN H 6GLN L 95LEU H 45 | 1.71A | 19.53 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | MET H 106GLY H 110GLN H 6GLN L 95LEU H 45 | 1.66A | 20.28 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | MET B 106GLY B 110GLN B 6GLN C 95LEU B 45 | 1.60A | 20.86 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | MET H 106GLY H 110GLN H 6GLN L 95LEU H 45 | 1.64A | 19.00 | None | ||
![]() | 5UC3_B_486B801_1 (GLUCOCORTICOIDRECEPTOR) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | MET H 106GLY H 110GLN H 6GLN L 95LEU H 45 | 1.59A | 20.86 | None | ||
![]() | 1NHZ_A_486A800_1 (GLUCOCORTICOIDRECEPTOR) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | MET B 106GLY B 110GLN B 6GLN C 95LEU B 45 | 1.65A | 19.00 | None |